Skip to content
healthcare.dev

efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi]

RxNorm concept 2043464, branded drug (sbd). Prescribable name: SYMFI 600 MG / 300 MG / 300 MG Oral Tablet.

RxCUI
2043464
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/2043464 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

Symfi (efavirenz 600 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet; Symfi (efavirenz 600 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG)) Oral Tablet; efavirenz 600 MG / 3TC 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi]; efavirenz 600 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi]

Related concepts

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2043464 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/2043464 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 2043464. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.